Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

OncoSec Announces Positive Data from Trial of ImmunoPulse IL-12, Pembrolizumab

americanpharmaceuticacreviewNovember 09, 2017

Tag: OncoSec , ImmunoPulse IL-12 , Pembrolizumab

PharmaSources Customer Service